US Nuclear CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
US Nuclear Corp. reported a reduced net loss for the nine months ended September 30, 2025, driven by one-time settlement income, but faces substantial doubt about its ability to continue as a going concern.
OTC.Pink
US Nuclear Corp. reported an 18.3% decline in sales and a 24.4% increase in net loss for the first half of 2025, raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
US Nuclear Corp. reported a significant net loss and revenue decline in Q1 2025, raising going concern doubts while disclosing ineffective disclosure controls.
OTC.Pink
US Nuclear Corp's Q3 2024 results show a slight revenue increase and reduced net loss, alongside significant debt restructuring and the introduction of Series A Preferred Stock.
OTC.Pink
US Nuclear Corp. saw a significant increase in sales during the second quarter of 2024, but the company still reported a net loss.
OTC.Pink
US Nuclear Corp. reports a net loss of $161,978 for the first quarter of 2024, an improvement compared to the $664,534 loss in the same period of 2023.